大孔树脂对三孢布拉霉菌产番茄红素的吸附性能研究

为利用大孔吸附树脂分离纯化三孢布拉霉菌发酵液番茄红素,考察了4种大孔树脂(HP20, HP2MG, SP825, SP207)对番茄红素的吸附 解吸特性,筛选出最佳树脂。结果表明,HP20大孔树脂对番茄红素具有较好的吸附 解吸性能,且吸附迅速,能在1h内达到吸附平衡。用含55%和60%异丙醇的丙酮不连续梯度洗脱,回收率可达89.55%,重结晶后可获得纯度95%以上的番茄红素,经红外、质谱、核磁等鉴定为天然型番茄红素。该方法简单,可操作性强,极具工业应用价值。     

Eremomycin的发酵条件优化及发酵产物的分离纯化

研究确定Nocardia orientalis NRRL18098发酵生产eremomycin的最佳工艺条件,以及对发酵产物进行分离纯化并得到eremomycin的纯品。通过正交设计方法优化发酵培养基的组成。采用树脂吸附、中压液相色谱技术相结合的方法对发酵产物进行分离纯化。在优化条件下,eremomycin的摇瓶发酵单位达115 mg/L,提高了63.5%,并采用树脂吸附和中压液相色谱相结合的方法能有效地将eremomycin从发酵液中分离出来,制备获得eremomycin精制品。     

高纯度白介素-3与假单胞菌外毒素融合蛋白的表达、纯化及质谱鉴定

旨在利用简单的表达纯化工艺,获得纯度较高、有活性的重组免疫毒素IL3-PE38KDEL并对其物理学及免疫学性质进行鉴定。利用PQE30-IL3-PE38KDEL/SG12009工程菌表达重组免疫毒素IL3-PE38KDEL,在提取包涵体后经一步强阳离子柱层析得到纯度较高的免疫毒素复性纯化产物,用Westenblotting、质谱、氨基测序等先进技术对产物鉴定。结果显示,发酵后目的蛋白表达量占总菌体的17.56%,经强阳离子柱层析纯化复性后的目的蛋白纯度达到90%以上,Western blotting、质谱、氨基测序结果均表明,纯化产物分子量为54.9kD且具有相应的免疫学活性,序列与预期序列完全一致。纯化复性方法对重组免疫毒素IL3-PE38KDEL的生物性质及纯度有较大影响,因此选择一种适当的纯化复性方法至关重要。     

产胶原酶的蜡样芽胞杆菌发酵条件优化及酶的分离纯化

【目的】优化蜡样芽胞杆菌R75E菌株产胶原酶的条件,并通过蛋白分离纯化技术获得高纯度胶原酶。【方法】利用单因素及正交试验优化蜡样芽胞杆菌R75E产胶原酶的发酵条件及发酵培养基,将发酵液离心除菌后得到粗酶液,对其依次通过硫酸铵分级沉淀、Butyl FF疏水层析及SuperdexTM 200凝胶过滤层析等方法对目标胶原酶进行分离纯化,利用SDS-PAGE电泳检测其纯度。【结果】优化后发酵条件为培养温度41°C、接种量6%、培养时间36 h,优化后发酵培养基为葡萄糖10 g/L、蛋白胨5 g/L、起始p H 7.0,粗酶液酶活力较优化前提高了2.9倍;将该粗酶液经过一系列纯化后得到纯度超过90%的胶原酶产物,其纯化倍数和回收率分别为18.4和1.1%。【结论】获得蜡样芽胞杆菌R75E的最佳产酶条件,并对胶原酶分离纯化的方法进行了探索,为微生物胶原酶的开发应用奠定基础。     

棘孢曲霉转化甜菊糖为甜菊醇及纯化莱鲍迪苷A

【目的】本工作对棘孢曲霉固体发酵抽提酶液转化甜菊糖进行了研究,并对转化产物进行鉴定及纯化分析。【方法】用高效液相色谱、液质联用及红外光谱等方法对转化新产物进行鉴定,对上清液中莱鲍迪苷A(RA)成分进行纯化。【结果】棘孢曲霉酶液在10 h内对甜菊糖中的甜菊苷(SS)、莱鲍迪苷C(RC)进行高效特异性转化,以沉淀的形式析出的转化产物经鉴定为甜菊醇,转化率高达98.0%,分离提纯后纯度为95.2%,回收率达84.0%.由于甜菊醇的沉淀分离,留在溶液中的RA更易被纯化。RA通过树脂吸附分离的回收率为80.5%.【结论】棘孢曲霉酶液对甜菊糖的一次转化可以同时得到甜菊醇和莱鲍迪苷A两种产品,是一种经济高效的工艺。     

浅紫灰链霉菌CQ01819及其次级代谢产物的定向发掘

【目的】采用特征次级代谢产物生物合成的保守功能基因探针,定向分离土壤中产生特征次级代谢产物的菌种资源,借助基因转录分析为导向的培养基优化方法,获得目标次生代谢产物。【方法】首先,根据5种特征次级代谢产物保守的合成功能基因设计简并引物,定向从土壤样品中筛选、分离并纯化菌株。然后,以RT-qPCR为指导开展目标产物的发酵培养基优化;最后,对菌株进行发酵,利用多种色谱技术分离纯化目标天然产物,并结合高分辨质谱与核磁共振等技术对所获得的化合物进行结构鉴定。【结果】从土壤中筛选得到了一株AHBA合酶基因和环氧化酶基因均为阳性的链霉菌菌株(编号为CQ01819),根据转录分析优化发酵培养基,最终从该菌株分离纯化得到了含有AHBA结构单元的丝裂霉素C、聚醚类抗生素莫能霉素A和缬吲霉素。【结论】本研究通过菌株的定向分离纯化,筛选得到了产生预期抗生素的浅紫灰链霉菌菌株CQ01819;基于RT-qPCR指导的发酵培养基优化,确定了菌株的发酵条件;获得发酵粗提物后,采用多种色谱整合技术和光谱分析策略,快速分离并鉴定了目标产物。该研究为目标菌种资源的定向筛选、菌株的发酵条件的快速优化和化合物的定向分离提供了较好的参考。     

重组干扰素-τ在大肠杆菌中的表达与纯化

目的:探讨干扰素(IFN)-τ在大肠杆菌中的表达及纯化。方法:含有IFN-τ基因的pBV220表达质粒转化大肠杆菌BL21,于42℃温控诱导重组菌表达IFN-τ。经过包涵体溶解、DEAE离子交换层析、硫酸铵沉淀及梯度透析,使重组IFN-τ获得纯化和复性。结果:诱导后的表达产物经SDS-PAGE分析,有相对分子质量约21000的条带。纯化复性后目的蛋白纯度可达90%。结论:工程菌可稳定高效地表达IFN-τ。硫酸铵沉淀结合阴离子交换是一种简便高效的纯化方法,可获得较高纯度的IFN-τ。     

重组胰高糖素样肽-1融合蛋白的纯化及其活性测定

主要探讨了发酵液中融合蛋白rh（GLP-1A2G）2-HSA的分离纯化过程。发酵上清液经超滤浓缩、离子交换层析、凝胶过滤分离得高纯度的rh（GLP-1A2G）2-HSA。纯化样品经SDS-PAGE检测为单一条带,HPLC分析纯度达98%,^125I标记后用TCA沉淀法测定放射性纯度达97%,符合药效学和药代动力学研究的需要,整个纯化过程回收率达到48.5%。通过细胞增殖实验表明纯化后的rh（GLP-1A2G）2-HSA具有类似GLP-1的促胰岛β细胞增殖活性,说明该分离过程保护了融合蛋白rh（GLP-1A2G）2-HSA的生物活性。通过融合蛋白rh（GLP-1A2G）2-HSA的纯化方法,可获得高纯度的重组融合蛋白rh（GLP-1A2G）2-HSA,为进一步的药效学和药代动力学研究奠定了基础。     

大肠杆菌表达Trx-rPA融合蛋白的复性纯化

大肠杆菌高密度发酵以包涵体形式表达融合蛋白Trx-rPA,表达量22%。包涵体蛋白洗涤后经金属螯合层析纯化,纯度达80%以上。经胱氨酸衍生,以脉冲加样形式复性,复性率可高达30%。经ETI-Sepharose纯化,复性的融合蛋白生物活性可达3.5×105IU/mgPr.。融合蛋白可被rEK酶切释放rPA,酶切效率达85%以上。酶切液经IDA-Sepharose和SP-Sepharose层析纯化,rPA纯度达98%以上,生物活性50万IU/mgPr.。1L发酵液经分离、复性及纯化后,可得高纯度rPA300mg以上。     

Breeding of partricin prodcing strain, purification of antifungal metabolite and its structure verifcation

链霉菌SIPI-A.2020是本实验室分离保藏的一株可能产生帕曲星的放线菌,本文对此菌株培养与发酵、抗菌活性物质的分离纯化及其结构验证进行了研究.经过菌种选育与发酵条件优化,与出发菌株相比,主要发酵产物X的发酵效价提高89.3％;通过对发酵液的分离纯化,得到了HPLC纯度分别为96.3％和95.6％的两个组分,经进一步UV、MS、NMR等分析,验证其为帕曲星B和帕曲星A.     

沉默lycB基因对雨生红球藻类胡萝卜素合成代谢的影响

雨生红球藻是一种淡水浮游单细胞绿藻, 逆境条件下可积累大量的类胡萝卜素。番茄红素是类胡萝卜素中的一种, 是类胡萝卜素合成代谢中的一个重要中间产物。番茄红素β-环化酶(LycB)是催化番茄红素形成β-胡萝卜素的关键酶。文章以杜氏盐藻lycB基因为干扰序列, 构建了含卡那霉素与阿特拉津双抗性的RNAi载体p1301-BS-RNAi。将其电转化进雨生红球藻细胞, 经抗性筛选、基因组PCR及RT-PCR筛选, 获得了16个独立的干扰株系。选取生长良好的7个进行高光诱导, 发现其番茄红素含量增加了99.4%, β-胡萝卜素含量减少了48.4%, 即通过异源的lycB-RNAi基因沉默可抑制番茄红素向β-胡萝卜素的转化。对比分析发现, 番茄红素增加量仅是β-胡萝卜素减少量的5%, 表明因lycB-RNAi抑制而产生的番茄红素的95%又被其他通路转换成了其他代谢产物, 因此要实现雨生红球藻番茄红素含量的大幅增长, 需协同调控其他代谢通路。     

Alteration of product specificity of Rhodobacter sphaeroides phytoene desaturase by directed evolution

Phytoene desaturases occurring in nature convert phytoene to either neurosporene or lycopene in most eubacteria. Approximately 10% of known phytoene desaturases, as in Rhodobacter, produce neurosporene, whereas the rest produce lycopene. These two types of enzymes, although similar in function, have relatively low similarity (below 60%) in terms of nucleotide or amino acid sequence. The mechanism controlling the product specificity of these enzymes is unclear. Here we used directed evolution to change the product of Rhodobacter sphaeroides phytoene desaturase (crtI gene product), a neurosporene-producing enzyme, to lycopene. Two generations of random mutagenesis were performed, from which three positive mutants were isolated and sequenced. We then used site-directed mutagenesis to determine the effect of each amino acid change. Gathering information from random mutagenesis, we further recombined the beneficial mutations by site-directed mutagenesis and increased the percent of lycopene production to 90%.     

三孢布拉霉发酵生产番茄红素的提取工艺及残留溶剂去除

用超声波皂化法从三孢布拉霉(Blakeslea trispora)发酵菌丝中提取番茄红素,对皂化条件、超声处理时间、提取温度和时间进行优化,得到番茄红素含量大于0.5%的番茄红素油树脂,总提取率达92.9%。提出溶剂提取与SC-CO2去除溶剂的技术路线,使番茄红素粗提物的溶剂残留符合标准。     

Effects of lycopene and tomato paste extracts on DNA and lipid oxidation in LNCaP human prostate cancer cells

Animal and epidemiological studies point to a cancer preventive/therapeutic role for tomato products and its antioxidant, lycopene. It is hypothesized that lycopene will behave as an antioxidant at low concentrations and as a prooxidant at high concentrations in LNCaP human prostate cancer cell culture systems. We characterized the antioxidant, and prooxidant effects of a hexane extract of tomato paste (TP) and water solubilized lycopene at different concentrations using a prostate cancer cell line. Placebo (5% triglyceride, Roche Inc.) was used as a control. After 6, 24 hr and 48 hr incubation, LNCaP cells were harvested and used for each measurement. Cellular proliferation was determined using the MTT colorimetric assay. Lycopene and TP hexane extract inhibited cell growth in a dose-dependent (0.1-50 microM lycopene) manner and growth inhibition was 55% and 35% at 1 microM lycopene and TP hexane extract, respectively after 48 hr incubation. The levels of 8-hydroxydeoxyguanosine/deoxyguanosine (an oxidative DNA damage product) was significantly increased starting at 5 microM lycopene from both TP hexane extract and pure lycopene after 24 and 48 hr incubation with no protection at the lower concentrations. Malondialdehyde formation (a lipid peroxidation product measured by HPLC separation of the MDA-TBA adduct) was significantly reduced at low concentrations (0.1-1 microM) of lycopene in all treatments. Clinically relevant concentrations of lycopene and the tomato fraction containing lycopene significantly reduced LNCaP cancer cell survival which can only be partially explained by increased DNA damage at high lycopene concentrations (> 5 microM). Low concentrations of lycopene acted as a lipid antioxidant but did not protect DNA.     

Bioavailability of all-trans and cis-isomers of lycopene

Lycopene, the predominant carotenoid in tomatoes, is among the major carotenoids in serum and tissues of Americans. Although about 90% of the lycopene in dietary sources is found in the linear, all-trans conformation, human tissues contain mainly cis-isomers. Several research groups have suggested that cis-isomers of lycopene are better absorbed than the all-trans form because of the shorter length of the cis-isomer, the greater solubility of cis-isomers in mixed micelles, and/or as a result of the lower tendency of cis-isomers to aggregate. Work with ferrets, a species that absorbs carotenoids intact, has demonstrated that whereas a lycopene dose, stomach, and intestinal contents contained 6-18% cis-lycopene, the mesenteric lymph secretions contained 77%-cis isomers. The ferret studies support the hypotheses that cis-isomers are substantially more bioavailable then all-trans lycopene. In vitro studies suggest that cis-isomers are more soluble in bile acid micelles and may be preferentially incorporated into chylomicrons. The implications of these findings are not yet clear. Rats appear to accumulate lycopene in tissues within the ranges reported for humans, suggesting that they can be used to study effects of lycopene isomers on disease processes. Investigations are underway to determine whether there are biological differences between all-trans and various cis-isomers of lycopene regarding its antioxidant properties or other biological functions.     

Lycopene inhibits proinflammatory cytokine and chemokine expression in adipose tissue

Obesity is associated with a low-grade inflammation which is correlated with an increased secretion of pro-inflammatory cytokines and chemokines by adipose tissue, suspected to contribute to the development of insulin resistance. Because lycopene is mostly stored in adipose tissue and possesses anti-inflammatory properties, we hypothesize that lycopene could reduce the production of proinflammatory markers in adipose tissue. In agreement with this hypothesis, we observed a decrease of inflammatory markers such as IL-6, MCP-1 and IL-1β at both the mRNA and protein level when explants of epididymal adipose tissue from mice fed with a high-fat diet were incubated with lycopene ex vivo. The same effect was reproduced with explants of adipose tissue preincubated in lycopene and then subjected to TNFα stimulation. The contribution of adipocytes and preadipocytes was evaluated. In both preadipocytes and differentiated 3T3-L1 adipocytes, lycopene preincubation for 24 h decreased the TNFα-mediated induction of IL-6 and MCP-1. Finally, the same results were reproduced with human adipocyte primary cultures. The molecular mechanism was also studied. In transient transfections, a decrease of the luciferase gene reporter under control of NF-κB responsive element was observed for cells incubated in the presence of lycopene and TNFα compared to TNFα alone. The involvement of the NF-κB pathway was confirmed by the modulation of IKKα/β phosphorylation by lycopene.Altogether, these results showed for the first time a limiting effect of lycopene on adipose tissue proinflammatory cytokine and chemokine production. Such an effect could prevent or limit the prevalence of obesity-associated pathologies, such as insulin resistance.     

Extraction conditions affecting supercritical fluid extraction (SFE) of lycopene from watermelon

Lycopene, a carotenoid linked to protection against certain forms of cancer, is found in produce such as papaya, red-fleshed tomatoes, grapefruit and watermelon. The preparation of a supercritical CO2 (SC-CO2) watermelon-lycopene extract could serve as a food grade source of this carotenoid. This study established preliminary conditions for enhancing SC-CO2 extraction of lycopene from watermelon. Freeze-dried watermelon was extracted with SC-CO2 and ethanol as an organic co-solvent. The lycopene concentration was determined by HPLC, with absorbance measured at 503 nm. In an initial set of experiments, the effects of extraction temperature (70-90 degrees C), pressure (20.7-41.4 MPa) and co-solvent ethanol addition (10-15%) were evaluated. A lycopene yield of 38 microg per gram of wet weight was obtained at 70 degrees C, 20.7 MPa, and 15% by volume ethanol. The extraction of fresh (non-freeze-dried) watermelon yielded 103+/-6 microg lycopene per gram fresh fruit weight. Of the parameters tested, temperature had the most effect on lycopene yield. Thus, in another set of experiments, the temperature was varied from 60-75 degrees C at an extraction pressure of 20.7 MPa in the presence of 15% ethanol. Studies showed that freeze-dried watermelon flesh loses lycopene in storage. In accounting for lycopene storage losses, lycopene yields at 60 degrees C extraction temperature were 14% greater than those obtained at 70 degrees C.     

Effects of lycopene-beadlet or tomato-powder feeding on carbon tetrachloride-induced hepatotoxicty in rats.

The carotenoid lycopene has been touted as possessing various antioxidant properties, but there are no demonstrations that lycopene inhibits tissue injury due to acute oxidant stress. Thus, the present study examined the effects of intake of lycopene or tomato extract, a rich source of lycopene, on acute liver injury caused by the oxidant carbon tetrachloride (CCl4). Feeding with tomato extract (10% tomato powder), but not with lycopene (0.25% lycopene beadlets), partially inhibited CCl4-induced hepatic injury based on the serum activities of sorbitol dehydrogenase and aspartate aminotransferase. No effect was seen for either lycopene or tomato extract on serum beta-glucuronidase activity, a marker of lysosomal injury. We concluded that tomato extract, but not lycopene, partially protected against acute liver injury due to chemically-induced oxidant stress.     

Protective Effect of Lycopene on Oxidative Stress and Cognitive Decline in Rotenone Induced Model of Parkinson’s Disease

Evidence from clinical and experimental studies indicate that oxidative stress is involved in pathogenesis of Parkinson’s disease. The present study was designed to investigate the neuroprotective potential of lycopene on oxidative stress and neurobehavioral abnormalities in rotenone induced PD. Rats were treated with rotenone (3 mg/kg body weight, intraperitoneally) for 30 days. NADH dehydrogenase a marker of rotenone action was observed to be significantly inhibited (35%) in striatum of treated animals. However, lycopene administration (10 mg/kg, orally) to the rotenone treated animals for 30 days increased the activity by 39% when compared to rotenone treated animals. Rotenone administration increased the MDA levels (75.15%) in striatum, whereas, lycopene administration to rotenone treated animals decreased the levels by 24.33%. Along with this, significant decrease in GSH levels (42.69%) was observed in rotenone treated animals. Lycopene supplementation on the other hand, increased the levels of GSH by 75.35% when compared with rotenone treated group. The activity of SOD was inhibited by 69% in rotenone treated animals and on lycopene supplementation; the activity increased by 12% when compared to controls. This was accompanied by cognitive and motor deficits in rotenone administered animals, which were reversed on lycopene treatment. Lycopene treatment also prevented release of cytochrome c from mitochondria. Collectively, these observations suggest that lycopene supplementation along with rotenone for 30 days prevented rotenone-induced alterations in antioxidants along with the prevention of rotenone induced oxidative stress and neurobehavioral deficits. The results provide an evidence for beneficial effect of lycopene supplementation in rotenone-induced PD and suggest therapeutic potential in neurodegenerative diseases involving accentuated oxidative stress.